Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other 1Gynecologic 1

Conditions

Neoplasm Metastasis 2Myelodysplastic Syndromes 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Glioblastoma 2Endometrial Neoplasms 2Diffuse Intrinsic Pontine Glioma 2Unspecified Adult Solid Tumor 1Triple Negative Breast Neoplasms 1Solid Tumors 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Obesity 1Neuroendocrine Tumors 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Gliosarcoma 1Fallopian Tube Neoplasms 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinosarcoma 1

Interventions

Specimen Handling 3Paclitaxel 3Nivolumab 3Carboplatin 3olaparib 2X-Rays 2Biopsy 2sargramostim 1pembrolizumab 1pazopanib 1pamiparib 1liposomal doxorubicin 1durvalumab 1ceralasertib 1cediranib 1atezolizumab 1apatinib 1Trabectedin 1Tissue Banks 1TIC10 compound 1Minimally Invasive Surgical Procedures 1Magnetic Resonance Spectroscopy 1LY-2157299 1Indocyanine Green 1Immunoglobulin G 1Gemcitabine 1Cyclophosphamide 1Colony-Stimulating Factors 1Cisplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinosarcoma × TIC10 compound × Clear all
NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
58 enrolled
GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡